<p> <p>Ob strapazierfähige Kleidung, duftende Kosmetik oder robuste Lebensmittelverpackungen: Chemikalien machen unseren Alltag komfortabel. Doch einige von ihnen bergen auch Risiken für Mensch und Umwelt. Ein neuer Erklärfilm des Umweltbundesamtes zeigt, wie die europäische Forschungsinitiative PARC dazu beiträgt, diese Risiken besser zu verstehen und zu reduzieren.</p> </p><p>Ob strapazierfähige Kleidung, duftende Kosmetik oder robuste Lebensmittelverpackungen: Chemikalien machen unseren Alltag komfortabel. Doch einige von ihnen bergen auch Risiken für Mensch und Umwelt. Ein neuer Erklärfilm des Umweltbundesamtes zeigt, wie die europäische Forschungsinitiative PARC dazu beiträgt, diese Risiken besser zu verstehen und zu reduzieren.</p><p> <p>In der EU sind über 26.000 Chemikalien registriert. Viele gelangen bereits während der Herstellung in Böden, Gewässer, Luft oder in den menschlichen Körper. <a href="https://www.umweltbundesamt.de/service/glossar/pfas">PFAS</a>, <a href="https://www.umweltbundesamt.de/service/glossar/pestizide">Pestizide</a> und Weichmacher können sich in der Umwelt anreichern, Gewässer gefährden oder den menschlichen Hormonhaushalt beeinflussen. Bei zahlreichen Stoffen ist noch gar nicht genau bekannt, welche langfristigen Folgen sie für Umwelt und Gesundheit haben.</p> <p>Hier setzt die Europäische Partnerschaft für die Bewertung von Risiken durch Chemikalien (PARC) an. Die Forschungsinitiative untersucht, wo Chemikalien vorkommen, wie sie wirken und welche Alternativen es gibt. Gleichzeitige entwickelt PARC neue Methoden für eine bessere Risikobewertung. Dafür arbeiten Wissenschaft, Behörden, Politik und Industrie aus ganz Europa zusammen, unter anderem über europaweite Messkampagnen. </p> <p>Einen wichtigen Beitrag leisten dabei die <a href="https://www.umweltbundesamt.de/themen/gesundheit/belastung-des-menschen-ermitteln/alise-deutsche-kinder-jugendstudie-zur">Deutsche Kinder- und Jugendstudie zur Umweltgesundheit (ALISE)</a> und die <a href="https://www.umweltbundesamt.de/themen/gesundheit/belastung-des-menschen-ermitteln/deutsche-umweltstudie-zur-gesundheit-geres">Deutsche Umweltstudie zur Gesundheit (GerES)</a>, die seit Jahrzehnten die Chemikalienbelastung der Bevölkerung in Deutschland untersuchen.</p> <p>Dank PARC können nationale Daten und Studienergebnisse europaweit geteilt und verglichen werden. So lassen sich Risiken schneller erkennen und Maßnahmen effektiver umsetzen – die Forschungsergebnisse unterstützen Behörden dabei, Chemikalien zu regulieren, wirksame Grenzwerte festzulegen und besonders schädliche Stoffe zu verbieten. Damit leistet PARC einen wichtigen Beitrag zur nachhaltigen Nutzung von Chemikalien und zum Schutz von Mensch und Umwelt.</p> <p><strong>Zum <a href="https://www.umweltbundesamt.de/service/glossar/uba">UBA</a>-Erklärfilm auf YouTube:</strong> <a href="https://www.youtube.com/watch?v=86-WK2N2QWI">PARC – EU-Partnerschaft für die Risikobewertung von Chemikalien</a></p> </p><p>Informationen für...</p>
Anzahl der Proben: 279 Gemessener Parameter: Abbauprodukt von Kreatinphosphat im Muskel und Gradmesser für Nierenfunktionsstörungen Probenart: 24h-Sammelurin Eine ideale Matrix für das Human-Biomonitoring, weil mit dem Urin Chemikalien und/oder deren Metabolite ausgeschiedenen werden, die zuvor in direktem Kontakt mit dem Organismus standen. Messungen im Urin können somit zuverlässige Aussagen über die interne Belastung des Menschen liefern. Probenahmegebiet: Halle/Saale Größte Stadt in Sachsen-Anhalt und alter Industriestandort in der ehemaligen DDR mit starkem Strukturwandel seit 1990.
During the first three years of the Partnership for the Assessment of Risks from Chemicals (PARC), we derived health-based human biomonitoring guidance values (HBM-GVs) for 11 substances to enable the direct health-related interpretation of human biomonitoring (HBM) results. HBM-GVs indicate the concentration threshold of the substance or its specific metabolite(s) in human biological samples up to which according to current knowledge no adverse health effects are expected, assuming exposure to the individual substance alone. New HBM-GVs are now available for the pesticides’ active ingredients gamma-/lambda-cyhalothrin, acetamiprid, and imidacloprid, the ortho-phthalate diisononyl phthalate (DiNP) and the ortho-phthalate substitute diethylhexyl terephthalate (DEHTP), the UV filters DHHB (diethylamino hydroxybenzoyl hexyl benzoate, Uvinul® A plus) and benzophenone-3, the metals aluminium and its inorganic compounds, methyl mercury and elemental/inorganic mercury, and nickel. In addition, we updated the HBM-GVs, which were derived as part of the European HBM4EU initiative using the mass balance approach, in light of new findings regarding the body mass normalised daily urine volumes and taking into account consistent rounding in the calculation and presentation of the values. For one substance, chromium VI, we updated HBM Exposure Equivalents for Cancer Risk (HBM-EECR) for workers exposed to highly soluble chromates, e.g. in the chrome-plating sector, and newly derived HBM-EECR for workers exposed to chromium (VI) oxides formed under hot conditions, e.g. in welding. In addition, we drew up an HBM-GV-related scoping document for selected per- and polyfluoroalkyl substances (PFAS). The main conclusions of the work described above are summarised in this publication. © 2026 The Authors.
Human biomonitoring (HBM) is a powerful tool for quantifying internal chemical levels via biological samples such as blood and urine. Between 2000 and 2017, global synthetic chemical production doubled from approximately 1.15 billion tonnes to 2.3 billion tonnes, with this trend continuing to increase. There has been an extensive expansion of national HBM programmes to evaluate actual chemical exposures and safeguard their citizens. A key factor in the development of HBM is to include policymakers and to utilise HBM data for policy impact. This study, part of the HBM4IRE (Human Biomonitoring for Ireland) feasibility study, employed a World Café approach for engaging 25 stakeholders from government agencies, industry, and academia to co-create a national HBM roadmap. Using a critical realist approach and thematic analysis of qualitative data, four key themes emerged from the discussion: (1) targeted HBM for exposure hotspots, (2) mapping HBM to EU and National policy frameworks, (3) monitoring chemical exposures as an early warning system, and (4) aligning HBM with national legislative needs. Results highlight HBM’s critical role in identifying at-risk groups (such as workers in high-exposure industries, children exposed to recycled materials like playground tyres) and validating policy effectiveness (e.g., lead restriction impacts). It also highlighted challenges such as data gaps, high costs, and limited baseline information. Study participants expressed a need for a governance framework, including a national HBM Steering Committee and inter-institutional collaboration, to bridge science-to-policy gaps, offering a scalable model for other nations to enhance chemical risk management, ensure regulatory compliance, and strengthen public health protection. Overall, stakeholders expressed a high interest and strong willingness in establishing a national HBM programme in Ireland, viewing this as an opportune time for Ireland to implement such a system. The approach adopted for this study could be utilised to engage different stakeholders across an array of relevant topics. Given its valuable outcomes, the HBM4IRE World Café approach has demonstrated that it can serve as a model for other countries to build consensus, identify gaps, and foster stakeholder ownership in establishing long-term and sustainable national HBM programmes. © 2026 The Authors.
Anzahl der Proben: 87 Gemessener Parameter: Unverzichtbare Zusatzgröße für die Ermittlung und Beurteilung der Nierenfunktion Probenart: 24h-Sammelurin Eine ideale Matrix für das Human-Biomonitoring, weil mit dem Urin Chemikalien und/oder deren Metabolite ausgeschiedenen werden, die zuvor in direktem Kontakt mit dem Organismus standen. Messungen im Urin können somit zuverlässige Aussagen über die interne Belastung des Menschen liefern. Probenahmegebiet: Ulm Kleine Universitätsstadt in Süddeutschland an der Donau.
Anzahl der Proben: 123 Gemessener Parameter: Unverzichtbare Zusatzgröße für die Ermittlung und Beurteilung der Nierenfunktion Probenart: 24h-Sammelurin Eine ideale Matrix für das Human-Biomonitoring, weil mit dem Urin Chemikalien und/oder deren Metabolite ausgeschiedenen werden, die zuvor in direktem Kontakt mit dem Organismus standen. Messungen im Urin können somit zuverlässige Aussagen über die interne Belastung des Menschen liefern. Probenahmegebiet: Münster Bedeutende Universitätsstadt sowie Dienstleistungs- und Verwaltungszentrum in Nordrhein-Westfalen.
Anzahl der Proben: 75 Gemessener Parameter: Gradmesser für die Nierenfunktion Probenart: 24h-Sammelurin Eine ideale Matrix für das Human-Biomonitoring, weil mit dem Urin Chemikalien und/oder deren Metabolite ausgeschiedenen werden, die zuvor in direktem Kontakt mit dem Organismus standen. Messungen im Urin können somit zuverlässige Aussagen über die interne Belastung des Menschen liefern. Probenahmegebiet: Halle/Saale Größte Stadt in Sachsen-Anhalt und alter Industriestandort in der ehemaligen DDR mit starkem Strukturwandel seit 1990.
Lead (Pb) and methylmercury (MeHg) are well-established developmental neurotoxicants, associated with adverse effects on cognition in children. This study estimates the environmental burden of disease associated with Pb and MeHg on IQ loss of children. Human biomonitoring surveys from five European countries were used to estimate exposure for children and women of childbearing age, covering all exposure sources and routes. Coupled with exposure–response functions we derived from meta-analyses, IQ points lost attributable to each metal were estimated. Assuming a normal distribution of IQ points, we calculated the resulting IQ score due to exposure and applied disability weights to calculate DALYs. Uncertainty (on model parameters) and intra-populational variability (exposure differences) were propagated through Monte Carlo simulations. The burden due to combined exposure to both substances was estimated for the French dataset, which met data requirements for a mixture assessment. The estimated IQ shift between exposed and theoretically unexposed individuals was higher for Pb than for MeHg. Pb was responsible for a median shift in IQ points of −0.36 (Sweden) to −0.47 (Czech Republic), while MeHg contributed to −0.03 (Czech Republic) to −0.08 (France) IQ points. We estimated a mean attributable burden from 950 to 1173 DALYs per 100,000 individuals for Pb, and 96 to 251 DALYs per 100,000 for MeHg across the studied countries. The burden of combined exposure in the French population was estimated at an average of −0.49 IQ points lost per individual, and 1,367 DALYs per 100,000 births. Our results highlight the necessity to strengthen regulatory measures to reduce lead exposure through key sources such as dust, tap water, and food, despite decreasing blood levels in Europe in the last few decades. Regarding MeHg, our study highlights the importance of maintaining targeted communication towards current and future parents, especially because dietary exposure remains the main exposure source. © 2026 The Authors.
The European Joint Programme HBM4EU was established to address politically relevant questions on chemical risks to public health through a targeted human biomonitoring research programme. Running from 2017 to 2022, it was co-financed by the EU's Horizon 2020 Research and Innovation Programme (grant agreement No. 733032) and national or institutional funds from participating partners. HBM4EU was the first large European initiative to establish a robust science-to-policy interface by systematically aligning research activities with concrete regulatory needs. The programme introduced a structured governance model that actively involved policy-makers at European and national levels, scientists from multiple disciplines, and other stakeholders. A transparent prioritisation process defined key chemical groups as scientific focus areas, each supported by dedicated topic leaders. These leaders formulated relevant policy questions and translated them into targeted scientific tasks implemented via annual work programmes. To support regulatory uptake, HBM4EU produced tailored, policy-oriented communication products for all priority chemicals. At the end of the project, a structured survey among project partners assessed collaboration between scientists and policy-makers, as well as coordination, management and knowledge transfer. The results highlighted factors enabling effective communication and mutual understanding at the science-policy interface. They showed that shared governance promoted transparency, fair distribution of effort and synergies, and underlined the importance of continuous dialogue to ensure lasting impact. Overall, the findings provide practical guidance for future EU-funded projects seeking strong scientific excellence and policy relevance. © 2026 The Authors.
Global chemical production is projected to increase sharply by 2050, intensifying concerns about population exposure and related health and environmental risks. Human biomonitoring (HBM) provides a direct measure of aggregate internal exposure to chemicals and can act as an early warning tool for emerging health risks. There are growing international efforts to strengthen chemicals management and integrated risk assessment, including the EU's One Substance, One Assessment (OSOA) framework. Systematic HBM data are increasingly recognised as essential for translating exposure information into actionable evidence for chemical risk assessment and policy development. Several countries have established national HBM programmes, demonstrating their value for public health, regulatory decision-making, transparency for citizens and chemical safety. Yet many countries still lack such programmes despite having capable laboratories or prior scientific HBM experience. Establishing a sustainable national HBM programme requires coordinated governance, stakeholder engagement, infrastructure, technical expertise, mechanisms for linking science to policy and communication strategies. This study addresses this gap by proposing a holistic and adaptable framework, informed by best practices identified across 14 countries. The framework outlines the key elements required for the establishment and operation of national HBM programmes, including governance structures that facilitate collaboration among relevant stakeholders through either cross-ministerial steering committees or centralised coordinating bodies. It further emphasises systematic chemical prioritisation, standardised operating procedures, quality assurance and quality control (QA/QC), harmonised sample collection and processing, transparent science-to-policy translation mechanisms, integration with existing health surveys, shared infrastructure, international collaboration, and strategic biobanking as essential components for ensuring comparability, cost-efficiency, and long-term sustainability. © 2026 The Authors.
| Organisation | Count |
|---|---|
| Bund | 582 |
| Europa | 3 |
| Kommune | 3 |
| Land | 35 |
| Wirtschaft | 1 |
| Wissenschaft | 28 |
| Zivilgesellschaft | 2 |
| Type | Count |
|---|---|
| Daten und Messstellen | 163 |
| Ereignis | 2 |
| Förderprogramm | 140 |
| Text | 273 |
| unbekannt | 19 |
| License | Count |
|---|---|
| Geschlossen | 440 |
| Offen | 152 |
| Unbekannt | 5 |
| Language | Count |
|---|---|
| Deutsch | 400 |
| Englisch | 404 |
| Resource type | Count |
|---|---|
| Archiv | 1 |
| Bild | 20 |
| Datei | 165 |
| Dokument | 39 |
| Keine | 321 |
| Unbekannt | 1 |
| Webdienst | 1 |
| Webseite | 256 |
| Topic | Count |
|---|---|
| Boden | 287 |
| Lebewesen und Lebensräume | 542 |
| Luft | 264 |
| Mensch und Umwelt | 597 |
| Wasser | 263 |
| Weitere | 583 |